Literature DB >> 23433574

Polygenic familial hypercholesterolaemia: does it matter?

Evan A Stein1, Frederick J Raal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23433574     DOI： 10.1016/S0140-6736(13)60187-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Recommendations for the management of patients with familial hypercholesterolemia.

Authors:  David I Feldman; Michael J Blaha; Raul D Santos; Steve R Jones; Roger S Blumenthal; Peter P Toth; Laurence S Sperling; Seth S Martin
Journal:  Curr Atheroscler Rep       Date:  2015-01       Impact factor: 5.113

Review 2.  Dyslipidemias and Cardiovascular Prevention: Tailoring Treatment According to Lipid Phenotype.

Authors:  Veronika Sanin; Vanessa Pfetsch; Wolfgang Koenig
Journal:  Curr Cardiol Rep       Date:  2017-07       Impact factor: 2.931

Review 3.  The genetics and screening of familial hypercholesterolaemia.

Authors:  Raymond Henderson; Maurice O'Kane; Victoria McGilligan; Steven Watterson
Journal:  J Biomed Sci       Date:  2016-04-16       Impact factor: 8.410

Review 4.  Update on Familial Hypercholesterolemia: Diagnosis, Cardiovascular Risk, and Novel Therapeutics.

Authors:  Sang Hak Lee
Journal:  Endocrinol Metab (Seoul)       Date:  2017-01-19

5.  Familial hypercholesterolemia in very young myocardial infarction.

Authors:  Sha Li; Hui-Wen Zhang; Yuan-Lin Guo; Na-Qiong Wu; Cheng-Gang Zhu; Xi Zhao; Di Sun; Xiong-Yi Gao; Ying Gao; Yan Zhang; Ping Qing; Xiao-Lin Li; Jing Sun; Geng Liu; Qian Dong; Rui-Xia Xu; Chuan-Jue Cui; Jian-Jun Li
Journal:  Sci Rep       Date:  2018-06-11       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.